The use of mesenchymal stem cells for regenerative medicine is becoming more popular than ever before - even though their clinical usage is limited. Many ethical and translational questions, as well as legal aspects and uncertainty regarding safety inhibit the growth of appropriate therapies from promising scientific approaches.This paper demonstrates the main problems of the translation from stem cell based therapies from basic science towards their clinical use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/a-1122-8916 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!